Editas Medicine, Inc. (EDIT) - Not Halal (Non-Compliant)
Editas Medicine, Inc. (EDIT) is classified as Not Halal (Non-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Biotechnology
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 4.9% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 67.2% | Threshold: 30% | Result: Fail
- Non-Permissible Income Ratio
- Value: 20.5% | Threshold: 5% | Result: Fail
Dividend Purification
Purification percentage: 20.51%.Based on the company's financial statements, approximately 20.51% of dividend income should be donated to charity for purification. This is derived from identified interest income (20.51% of total income). Some scholars may differ on the exact calculation method.
About Editas Medicine, Inc.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Frequently Asked Questions
Is Editas Medicine, Inc. (EDIT) stock halal to invest in?
According to AAOIFI Shariah screening standards, Editas Medicine, Inc. (EDIT) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.

